LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

2 result(s)
Filter and sort
2 result(s)
Protocol > Research Protocol

An evaluation of false positive HIV results due to testing errors

Maparo TMS
1 June 2014
An unacceptably high frequency of false positive HIV test results has been reported in various settings. Given the severity and implications of an HIV+ diagnosis, a false positive result is likely to be psychologically traumatic and may result in inappropriate and potentially harmful treatment. The current HIV testing algorithm being used in Zimbabwe does not include repeat testing for HIV positive results, and it is not currently known whether testing errors are leading to false positive diagnoses at a significant rate. WHO recommends that an additional specimen for testing be collected at some point after the initial diagnosis is made. This procedure aims to rule out possible technical or clerical errors including specimen mislabelling and transcription errors.
STUDY OBJECTIVE:
To evaluate the number of false positive HIV results due to testing errors, using the WHO retesting recommendations, in 6 clinics in Harare, Zimbabwe.
More
Journal Article > ResearchFull Text

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe

PLOS One. 2 March 2018; Volume 13 (Issue 3); DOI:10.1371/journal.pone.0193577
Ndlovu M, Fajardo E, Mbofana F, Maparo TMS, Garone DB,  et al.
PLOS One. 2 March 2018; Volume 13 (Issue 3); DOI:10.1371/journal.pone.0193577
HIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. GeneXpert (Cepheid, CA, USA) is a polyvalent near point-of-care platform and is widely implemented for Xpert MTB/RIF diagnosis. This study sought to evaluate the operational feasibility of integrated HIV VL, EID and MTB/RIF testing in new GeneXpert platforms.More